Profile | GDS2987 / GI_29337288-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 683.1 | 93 |
GSM215244 | HMVEC_vehicle_rep2 | 874.8 | 94 |
GSM215253 | HMVEC_vehicle_rep3 | 751.5 | 93 |
GSM215254 | HMVEC_atorvastatin_rep1 | 1393.7 | 96 |
GSM215282 | HMVEC_atorvastatin_rep3 | 1384.3 | 96 |
GSM215344 | HMVEC_atorvastatin_rep2 | 1329.4 | 96 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 660.9 | 92 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 813 | 93 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 956.3 | 94 |
GSM215294 | HMVEC_SLx2119_rep1 | 434.6 | 90 |
GSM215295 | HMVEC_SLx2119_rep2 | 502.2 | 90 |
GSM215296 | HMVEC_SLx2119_rep3 | 485.6 | 90 |
GSM215297 | PASMC_vehicle_rep1 | ||
GSM215298 | PASMC_vehicle_rep2 | 27.4 | 40 |
GSM215310 | PASMC_vehicle_rep3 | ||
GSM215311 | PASMC_atorvastatin_rep1 | 3.3 | 6 |
GSM215312 | PASMC_atorvastatin_rep2 | 26.9 | 40 |
GSM215313 | PASMC_atorvastatin_rep3 | ||
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | ||
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 12.2 | 24 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | ||
GSM215327 | PASMC_SLx2119_rep1 | ||
GSM215328 | PASMC_SLx2119_rep2 | ||
GSM215329 | PASMC_SLx2119_rep3 | 42 | 60 |
GSM215330 | Fibroblasts_vehicle_rep1 | 28 | 53 |
GSM215331 | Fibroblasts_vehicle_rep2 | 34.9 | 62 |
GSM215332 | Fibroblasts_vehicle_rep3 | 19.3 | 52 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 24.5 | 53 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 51.6 | 69 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 54.2 | 68 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 17.9 | 50 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 17.1 | 48 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 29 | 59 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 21.1 | 51 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 26.9 | 57 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 26.5 | 54 |